Anticoagulant therapy during cardiopulmonary bypass
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11239-008-0280-4.pdf
Reference110 articles.
1. Koster A, Fischer T, Gruendel M et al (2003) Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation. J Cardiothorac Vasc Anesth 17(2):171–175. doi: 10.1053/jcan.2003.42
2. Spanier TB, Oz MC, Minanov OP et al (1998) Heparinless cardiopulmonary bypass with active-site blocked factor IXa: a preliminary study on the dog. J Thorac Cardiovasc Surg 115(5):1179–1188. doi: 10.1016/S0022-5223(98)70419-2
3. Hiramatsu Y, Gikakis N, Gorman JH 3rd et al (1997) A baboon model for hematologic studies of cardiopulmonary bypass. J Lab Clin Med 130(4):412–420. doi: 10.1016/S0022-2143(97)90041-X
4. Edmunds LH Jr, Colman RW (2006) Thrombin during cardiopulmonary bypass. Ann Thorac Surg 82(6):2315–2322. doi: 10.1016/j.athoracsur.2006.06.072
5. Casati V, Gerli C, Franco A et al (2001) Activation of coagulation and fibrinolysis during coronary surgery: on-pump versus off-pump techniques. Anesthesiology 95(5):1103–1109. doi: 10.1097/00000542-200111000-00013
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Generation of an anticoagulant aptamer that targets factor V/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples;Cell Chemical Biology;2022-02
2. Aptamer-based protein inhibitors;RNA Therapeutics;2022
3. Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models;Pharmaceutics;2021-03-09
4. Aptamers for Thrombotic Diseases;Aptamers for Medical Applications;2021
5. Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass;Nature Biotechnology;2018-06-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3